Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With Diet and Metformin
暂无分享,去创建一个
[1] G. Boden. Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.
[2] A. Vaag,et al. Intracellular Glucose and Fat Metabolism in Identical Twins Discordant for Non‐insulin‐dependent Diabetes Mellitus (NIDDM): Acquired Versus Genetic Metabolic Defects? , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[3] L. S. Hermann. Clinical Pharmacology of Biguanides , 1996 .
[4] G Dailey,et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[5] E. Ferrannini,et al. Acute Antihyperglycemic Mechanisms of Metformin in NIDDM: Evidence for Suppression of Lipid Oxidation and Hepatic Glucose Production , 1994, Diabetes.
[6] R. Marfella,et al. Metformin Improves Glucose, Lipid Metabolism, and Reduces Blood Pressure in Hypertensive, Obese Women , 1993, Diabetes Care.
[7] C. Sum,et al. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. , 1993, Metabolism: clinical and experimental.
[8] N. Wiernsperger,et al. DEMONSTRATION OF DEFECTIVE GLUCOSE UPTAKE AND STORAGE IN ERYTHROCYTES FROM NON‐INSULIN DEPENDENT DIABETIC PATIENTS AND EFFECTS OF METFORMIN , 1993, Clinical and experimental pharmacology & physiology.
[9] Lawrence A Leiter,et al. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. , 1992, The Journal of clinical investigation.
[10] C. Bailey. Biguanides and NIDDM , 1992, Diabetes Care.
[11] A. Vaag,et al. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[12] L. Groop,et al. Metformin Normalizes Nonoxidative Glucose Metabolism in Insulin-Resistant Normoglycemic First-Degree Relatives of Patients With NIDDM , 1992, Diabetes.
[13] G. Reaven,et al. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria. , 1991, Diabete & metabolisme.
[14] A. Tiengo,et al. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. , 1991, Diabete & metabolisme.
[15] J. Zierath,et al. Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle. , 1991, Diabete & metabolisme.
[16] R. Taylor,et al. The Effect of Sulphonylurea Therapy on Skeletal Muscle Glycogen Synthase Activity and Insulin Secretion in Newly Presenting Type 2 (Non‐insulin‐dependent) Diabetic Patients , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[17] R. Henry,et al. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. , 1991, The Journal of clinical investigation.
[18] R. DeFronzo,et al. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. , 1990, Metabolism: clinical and experimental.
[19] C. Bogardus,et al. Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. , 1990, The Journal of clinical investigation.
[20] R G Shulman,et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.
[21] G. Reaven,et al. Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients , 1990, Diabetes Care.
[22] L. Groop,et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.
[23] B V Howard,et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.
[24] J. Olefsky,et al. Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus , 1986, Diabetes.
[25] E. B. Jackson,et al. Perspectives on , 1981, J. Am. Soc. Inf. Sci..
[26] H. Mortensen. Quantitative determination of hemoglobin A1c by thin-layer isoelectric focusing. , 1980, Journal of chromatography.
[27] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[28] S. Muntoni. Inhibition of fatty acid oxidation by biguanides: implications for metabolic physiopathology. , 1974, Advances in lipid research.